Business · 10/08/1994
FDA Amends Antibiotic Drug Regulations for Rifabutin and Rifabutin Capsules
The Food and Drug Administration (FDA) is amending the antibiotic drug regulations to include standards for rifabutin and rifabutin capsules after receiving sufficient data from the manufacturer to establish their safety and efficacy.
Original source language: Federal Register — Health and Human ServicesOpen original release →